Peppermint
Peppermint is an AI-powered financial operations platform built exclusively for clinical research organizations. It connects to existing CTMS, EDC, and accounting systems to automate billing, reconcile payments, and provide real-time revenue visibility, combining intelligent automation with expert human billers for judgment-based decisions. The platform has helped partners reduce days sales outstanding by 3x and reclaim 25% of staff time previously spent on billing.
- Financial Technology
- Artificial Intelligence
- Software Only
Funding
Raised to date
$4.7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 1 round
BMBTDH+3$4.7M · Seed
Announced Oct 2026 · from article date
Disclosed cumulative: $4.7M
Founders
Founder details are not available yet.
Product
Problem
Clinical research finance is fragmented across contracts, CTMS, payment portals, spreadsheets, bank accounts, and accounting systems that were never designed to work together. This patchwork forces manual reconciliation, causing revenue leaks, delayed payments, and a lack of visibility into what each study actually earns. One-third of sites have more than 90 days' worth of overdue receivables, and 50% have three months or less of operating capital.
Solution
Peppermint provides an AI-powered financial operations platform designed exclusively for clinical research. The platform connects to existing CTMS, EDC, and accounting systems, ingesting data to cross-reference trial contracts against payment history and billed activities. It validates every visit and procedure at the source, invoices instantly and continuously, and reconciles payments against study, visit, invoice, and site records. Expert human billers handle decisions requiring judgment, such as ambiguous contract terms or unusual payments, while the AI scales the process at machine speed. This gives finance leaders a live view of key metrics including activity-to-invoice time, outstanding accounts receivable with aging, and projected revenue by study.
Target Audience
Primary customers are independent research sites, site networks, hospital systems, and academic medical centers that conduct clinical trials and need to streamline their revenue cycle and gain financial visibility across their research portfolios.
Features
- Real-time activity capture that reviews data capture accuracy to ensure billing is correct before invoices go out
- Line-by-line invoice accuracy with every line item checked against the clinical trial agreement and budget rules
- Continuous invoice creation that generates sponsor-ready invoices the moment activity is confirmed, rather than at month's end
- Automated sponsor/CRO follow-up that chases aging invoices until paid and works disputes to resolution
- Always-on payment reconciliation that matches every payment to study, visit, invoice, and site directly from bank data
- Proactive revenue recovery that identifies unbilled activities, amendment changes, and underpayments
- Full-picture leadership visibility showing collected, outstanding, and expected revenue by study, always current
- No forced system change, no disruption to workflows, and no CTMS or EDC replacement required